BRD7 and melanoma: Our analysis of publicly available melanoma datasets (Riker and Xu melanoma datasets) revealed that BRD7 is significantly overexpressed in metastatic melanoma patient samples as compared to the primary site samples and is also present at higher levels in advanced-stage melanoma patient samples (Figure S2A,B).